Ms. Meenu’s Ph.D. research abstract titled “Phase III Randomized Placebo-Controlled Trial on Repurposing of Olanzapine for the Prevention of Radiotherapy-Induced Nausea and Vomiting (RINV)” was showcased at the event, where she was one of only five global recipients of the Special Merit Award. Notably, she is the sole awardee from the Asian region.
Her groundbreaking research, conducted under the mentorship of Dr. Debnarayan Dutta and Dr. Narmadha M. P., will be published in the Journal of Clinical Oncology, a leading journal in oncology research.